Genome-Wide miRNA Expression Alterations in Nucleus Accumbens Provide Insights into Chronic Stress and Treatment in Depression

Nucleus Accumbens (NAc) is a key area for reward and response to stress, and microRNA plays a critical role in depression. However, the miRNA expression alteration in NAc during the stress-induced depression and antidepressant treatment, as well as its biological significance, remains mostly unexplored. We randomly selected 24 rats to control, chronic unpredictable mild stress (CUMS) and CUMS+Escitalopram treatment group (8 each). Nucleus Accumbens of rats from 3 groups were microRNA-sequenced. We applied differential expression analysis and co-expression analyses on expression data. After target gene prediction by Targetscan, network and pathway analysis were also performed. 18/8 differential expressing (DE) miRNA (FDR <0.05, log2FC >1 or <−1) are observed in control VS case/ case VS treatment comparison,2 of them are overlapping. We observed a negative correlation between log2FC(control vs. case) and log2FC (case vs. treatment). Weighted co-expression analysis discovered a module (M1) with a strong positive correlation with stress (R=0.96, P=0.003), and another module(M7) with a positive correlation with anhedonia (R=0.89, P=0.02). In miRNA-mRNA networks of M1, TFRC had most neighbors. Strikingly, pathway analysis of Kyoto encyclopedia of genes and genomes (KEGG) reveals enrichment in Ras signaling pathway of predicted target genes of miRNAs associated with both depression, treatment and anhedonia. indicating its potential involvement in depression. Conclusion: Escitalopram treatment can significantly reverse both behavioral and NAc miRNA abnormality caused by chronic stress. TFRC were strongly regulated in stress and/or antidepressant treatment. The Ras-signaling pathway may influence both onset, symptom and treatment response of stress-induced depression.

[1]  A. Carvalho,et al.  The miRNome of bipolar disorder. , 2017, Journal of affective disorders.

[2]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[3]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[4]  J. Smyth,et al.  Timing matters: the interval between acute stressors within chronic mild stress modifies behavioral and physiologic stress responses in male rats , 2018, Stress.

[5]  Zachary S. Lorsch,et al.  Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress , 2015, The Journal of Neuroscience.

[6]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[7]  I. Armando,et al.  Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists , 2005, Regulatory Peptides.

[8]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[9]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[10]  Xuegong Zhang,et al.  DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..

[11]  Scott J. Russo,et al.  The brain reward circuitry in mood disorders , 2013, Nature Reviews Neuroscience.

[12]  N. Wu,et al.  Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases , 2013, Cellular and Molecular Neurobiology.

[13]  Yaping Wang,et al.  G-CSF improves CUMS-induced depressive behaviors through downregulating Ras/ERK/MAPK signaling pathway. , 2016, Biochemical and biophysical research communications.

[14]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[15]  M. Barbosa,et al.  Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications , 2015, Journal of Medical Genetics.

[16]  A. Amare,et al.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry , 2017, EPMA Journal.

[17]  Chia-Chen Liu,et al.  Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants. , 2015, Journal of affective disorders.

[18]  Zhiheng Xu,et al.  Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity , 2016, Scientific Reports.

[19]  J. Clayton-Smith,et al.  Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder , 2010, Clinical dysmorphology.

[20]  L. Giner,et al.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime , 2018, Current Psychiatry Reports.

[21]  G. Turecki,et al.  Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants , 2017, CNS Drugs.

[22]  K. Ritchie,et al.  Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression , 2013, Translational Psychiatry.

[23]  Hua Liu,et al.  Chronic Unpredictable Mild Stress Causing Cardiac and Thoracic Spinal Cord Electrophysiological Abnormalities May Be Associated with Increased Cardiac Expression of Serotonin and Growth-Associated Protein-43 in Rats , 2018, BioMed research international.

[24]  Zachary S. Lorsch,et al.  Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility , 2016, Neuron.

[25]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[26]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[27]  Guanghua Xiao,et al.  Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli , 2007, Neuron.

[28]  Stephen J. Guter,et al.  Co‐occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion , 2013, American journal of medical genetics. Part A.